BA
ZYNE

Bristlecone Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bristlecone Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-672
Closed -$6K – 268
2017
Q3 		$6K Buy
+672
New +$6K ﹤0.01% 270